Accueil
Mots-clés
Thésaurus mots-clés > Disciplines diverses > Spécialités médicales en rapport avec les addictions > PHARMACOLOGIE
PHARMACOLOGIESynonyme(s)NEUROPHARMACOLOGIE |
Documents disponibles dans cette catégorie (1094)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
M. BAGGOTT ; L. JEROME ; R. STUART | Sarasota : MAPS ; Multidisciplinary Association for Psychedelic Studies | 2001This document is divided into five chapters, each summarizing an area of MDMA research: clinical studies; information on illicit users, neurotoxicity research in animals; neurotoxicity research in humans; and adverse events in illicit users. App[...]Article : Périodique
The illicit marketplace of substances of abuse continually offers for sale legal alternatives to controlled drugs to a large public. In recent years, a new group of designer drugs, the synthetic cathinones, has emerged as a new trend, particular[...]Rapport
This publication presents the data and findings of the risk assessment on 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC), carried out by the extended Scientific Committee of the EMCDDA on 19 November 2021. On the b[...]Rapport
This publication presents the data and findings of the risk assessment on 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2021. On the b[...]Article : Périodique
M. COPPOLA ; R. MONDOLA |In recent years, the spread of new psychoactive substances has dramatically increased in term of availability of both number of compounds and chemical families. In November 2012, 4,4'-Dimethylaminorex (4,4'-DMAR), a novel synthetic stimulant, wa[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Article : Périodique
G. C. HADLOCK ; K. M. WEBB ; L. M. McFADDEN ; P. W. CHU ; J. D. ELLIS ; S. C. ALLEN ; D. M. ANDRENYAK ; P. L. VIEIRA-BROCK ; C. L. GERMAN ; K. M. CONRAD ; A. J. HOONAKKER ; J. W. GIBB ; D. G. WILKINS ; G. R. HANSON ; A. E. FLECKENSTEIN |The designer stimulant 4-methylmethcathinone (mephedrone) is among the most popular of the derivatives of the naturally occurring psychostimulant cathinone. Mephedrone has been readily available for legal purchase both online and in some stores [...]Rapport
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on 4F-MDMB-BICA. The report is intended for policymakers and decision-makers in the institu[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant [...]Article : Périodique
Issues: 5-(2-aminopropyl)indole (5-IT) is a new psychoactive substance, a 'legal high', that recently invaded the drug arena in Europe and has already led to numerous intoxications and fatalities. Knowledge upon its pharmacology and toxicity is [...]Article : Périodique
C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO |OBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]Périodique
*** | 1994FRANÇAIS : Compte rendu d'un congrès organisé le 20 et 21 octobre 1993 à Lugano par le Schweizer Akademie des Medizinischen Wissenschaften à l'occasion du 50ème anniversaire de la découverte des effets psychotropes de LSD. Des pionniers de la r[...]Rapport
This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 N[...]